CAJ | 학술논문

胶质瘤（Glioma）是成人脑肿瘤中最常见的颅内恶性肿瘤。手术、术后替莫唑胺（Temozolomide， TMZ）联合放疗以及替莫唑胺辅助化疗是目前胶质瘤的标准治疗方案。尽管如此，神经胶质瘤的预后仍然很差。本文主要介绍神经胶质瘤的综合治疗，尤其是化学治疗的相关研究进展。
효질류（Glioma）시성인뇌종류중최상견적로내악성종류。수술、술후체막서알（Temozolomide， TMZ）연합방료이급체막서알보조화료시목전효질류적표준치료방안。진관여차，신경효질류적예후잉연흔차。본문주요개소신경효질류적종합치료，우기시화학치료적상관연구진전。
Gliobma is one of the most common intracranial malignant tumors in the adult brain tumors. Surgery, temo-zolomide combined with radiotherapy postoperatively and adjuvant chemotherapy with temozolomide have been established as the standard treatment options for glioma. Nevertheless, the prognosis for the patient with gliomas remains poor. This ar-ticle introduces the comprehensive treatment for the glioma, especially the progress on chemotherapy.